[{"uuid": "58f9048a-f9fd-4a9c-bb44-fc416e87bcc6", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Biphasic mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": "", "days_to_last_followup": "125", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e6dd3003-34e8-47c9-995e-e865d4c09e59", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage II", "histological_type": "Epithelioid mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "", "days_to_last_followup": "256", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "46", "end": "155", "duration": 109, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed", "start": "46", "end": "155", "duration": 109, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "691dd9d3-f3ef-446b-8f9e-2cde644bd96c", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": "1302", "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 7, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Dasatinib", "start": "54", "end": "93", "duration": 39, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Dasatinib", "start": "194", "end": "908", "duration": 714, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "197", "end": "286", "duration": 89, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed", "start": "197", "end": "286", "duration": 89, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Cediranib", "start": "1084", "end": "1265", "duration": 181, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "1084", "end": "1265", "duration": 181, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed", "start": "1084", "end": "1265", "duration": 181, "dosis": null, "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": "External", "start": "130", "end": "164", "duration": 34, "dosis": "60", "dosis_unit": "Gy"}, {"type": "External", "start": "717", "end": "735", "duration": 18, "dosis": "70", "dosis_unit": "Gy"}]}, {"uuid": "5f637fe2-94b4-4a04-a660-342cfbabc351", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": "949", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": null, "start": "344", "end": "394", "duration": 50, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3e84d0e4-dd81-4da1-826c-b671c3ad5ca3", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Biphasic mesothelioma", "days_to_death": "142", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "79c81669-5c91-401c-8b55-f74a79615306", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage IV", "histological_type": "Epithelioid mesothelioma", "days_to_death": "255", "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Ancillary", "name": "Porfimer Sodium(Photofin)", "start": "70", "end": "73", "duration": 3, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5affd9eb-c10c-4084-9959-2abbdf3deb68", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "", "days_to_last_followup": "1025", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "068bdc93-47a0-4530-b680-73ce13ea07ed", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Biphasic mesothelioma", "days_to_death": "158", "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": null, "name": null, "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "adfae3ca-e159-419a-a2d0-f8288f87665d", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Biphasic mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": "49", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "cc31f199-c752-43c5-9234-ae452a4fafde", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage II", "histological_type": "Epithelioid mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": "", "days_to_last_followup": "414", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Pemetrexed", "start": null, "end": "96", "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": null, "end": "96", "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Vaccine", "name": "WT-1 Vaccine", "start": "151", "end": "243", "duration": 92, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "cbd6c00e-fe3e-4cc2-bf93-4a173e3b9c47", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Biphasic mesothelioma", "days_to_death": "168", "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "52", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "139", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "ALIMTA", "start": "139", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "387fde0d-16e4-40f0-8c21-7586479cca6a", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage II", "histological_type": "Biphasic mesothelioma", "days_to_death": "78", "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "12", "end": "12", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed", "start": "12", "end": "12", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "50a07dae-bbf9-47a2-9690-59d60ca2b039", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage IV", "histological_type": "Epithelioid mesothelioma", "days_to_death": "1675", "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "67d0188e-0e21-40a3-b932-0f1e36ac3ed1", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": "57", "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a2b78cac-3e52-4e15-8d87-d5ccbab000e3", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": "", "days_to_last_followup": "108", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "177", "end": "238", "duration": 61, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Alimta", "start": "177", "end": "238", "duration": 61, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "268", "end": "322", "duration": 54, "dosis": "56", "dosis_unit": "Gy"}]}, {"uuid": "9e925eae-2fad-4e34-9330-0744e81e4453", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage IV", "histological_type": "Diffuse malignant mesothelioma - NOS", "days_to_death": "546", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "0", "end": "0", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "525", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "525", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9baf2918-24e2-491e-bf4d-68764f7de63f", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": "361", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Dasatinib", "start": "69", "end": "96", "duration": 27, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "28381e4a-ea5f-41b8-8b71-909d20be81b7", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage I", "histological_type": "Epithelioid mesothelioma", "days_to_death": "2459", "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 3, "drug_details": [{"type": null, "name": "Tetrathiomolybdate", "start": "248", "end": "406", "duration": 158, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Alimta", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "79d641ed-838c-4132-98ae-9afb5e572edf", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage IV", "histological_type": "Biphasic mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": "1150", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Tivantinib (ARQ-197)", "start": "910", "end": "1022", "duration": 112, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1b18f56e-4adc-41ac-9d45-9a108c7b59ea", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": "283", "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Ancillary", "name": "2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-alpha (HPPH or Photochlor)", "start": "24", "end": "27", "duration": 3, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "161c7c00-16fc-4254-b94f-355ce9528801", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage II", "histological_type": "Epithelioid mesothelioma", "days_to_death": "2790", "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": null, "name": "Tetrathiomolybdate", "start": "38", "end": "1056", "duration": 1018, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4e7c61d4-b7b2-46a4-9bf6-7f3d08ad5458", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage II", "histological_type": "Biphasic mesothelioma", "days_to_death": "333", "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "26", "end": "144", "duration": 118, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Alimta", "start": "26", "end": "144", "duration": 118, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e66f8d5e-96f3-41bf-8366-c4bff7f0bc8d", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage II", "histological_type": "Diffuse malignant mesothelioma - NOS", "days_to_death": "1715", "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 2, "drug_details": [{"type": "Targeted Molecular therapy", "name": "dasatinib", "start": "52", "end": "71", "duration": 19, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Cediranib", "start": "898", "end": "919", "duration": 21, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "155", "end": "190", "duration": 35, "dosis": "50", "dosis_unit": "Gy"}]}, {"uuid": "0ef6b764-f7ba-40d4-aa6e-095058802773", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Biphasic mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": "", "days_to_last_followup": "1299", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "190", "end": "270", "duration": 80, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Alimta", "start": "190", "end": "270", "duration": 80, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2d544d39-7926-409a-92c4-5bdfbf843062", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": "469", "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Ancillary", "name": "Porfimer Sodium (Photofin)", "start": "37", "end": "40", "duration": 3, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b6475822-5eb0-456e-b841-d579e67a5cb8", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": "709", "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemzar", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8889eb23-78d8-4cd9-9719-16e3e0317c29", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": "133", "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "cec42dee-2309-41af-95de-9b8b6697693e", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage IV", "histological_type": "Diffuse malignant mesothelioma - NOS", "days_to_death": "84", "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d8a84d8a-c662-4336-9c24-3a60fca2bed1", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": "457", "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Ancillary", "name": "Porfimer Sodium (Photofin)", "start": "61", "end": "64", "duration": 3, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f93734f5-4e93-408d-af60-1af2261fb976", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage II", "histological_type": "Epithelioid mesothelioma", "days_to_death": "385", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 4, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Dasatinib", "start": "47", "end": "79", "duration": 32, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Tarceva", "start": "221", "end": "275", "duration": 54, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "gemcitabine", "start": "221", "end": "264", "duration": 43, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "R1507", "start": "221", "end": "271", "duration": 50, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "132", "end": "152", "duration": 20, "dosis": "45", "dosis_unit": "Gy"}]}, {"uuid": "aed847cf-11d9-4037-9234-f21b6a5a6ad0", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage I", "histological_type": "Epithelioid mesothelioma", "days_to_death": "434", "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a0f916ee-7332-4669-a9a4-8316530ad07d", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": "1261", "age_at_initial_pathologic_diagnosis": "42", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Ancillary", "name": "Porfimer Sodium (Photofrin)", "start": "11", "end": "11", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0e2a5791-91e6-48bc-bf93-f57d1cfbc14c", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage II", "histological_type": "Biphasic mesothelioma", "days_to_death": "456", "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "138", "end": "256", "duration": 118, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed", "start": "138", "end": "256", "duration": 118, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "125", "end": "127", "duration": 2, "dosis": "21", "dosis_unit": "Gy"}]}, {"uuid": "1308cad3-72ba-427a-a955-ea279c3b0122", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage IA", "histological_type": "Sarcomatoid mesothelioma", "days_to_death": "185", "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatinum", "start": "53", "end": "53", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5c99b119-5134-4633-a427-b5d2f7b1701f", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Biphasic mesothelioma", "days_to_death": "982", "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Ancillary", "name": "2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-alpha (HPPH or Photochlor)", "start": "487", "end": "490", "duration": 3, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7ac59c4f-d45a-4ff8-8242-402e55663c00", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage IV", "histological_type": "Epithelioid mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": "", "days_to_last_followup": "484", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 3, "drug_details": [{"type": "Vaccine", "name": "GL-ONC1", "start": "34", "end": "34", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed", "start": "106", "end": "170", "duration": 64, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "106", "end": "170", "duration": 64, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "254", "end": "297", "duration": 43, "dosis": "5220", "dosis_unit": "cGy"}]}, {"uuid": "d9c52beb-4efe-4367-84bb-1629faab21fa", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage IV", "histological_type": "Epithelioid mesothelioma", "days_to_death": "39", "age_at_initial_pathologic_diagnosis": "28", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b5e5b5b0-bb33-4f11-88db-d9469d2e148a", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": "844", "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f311ca40-c319-4c50-a0ab-60c79aa8f564", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage I", "histological_type": "Biphasic mesothelioma", "days_to_death": "414", "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 3, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Dasatinib", "start": "35", "end": "61", "duration": 26, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Vorinostat", "start": "321", "end": "370", "duration": 49, "dosis": null, "dosis_unit": null}, {"type": null, "name": "Cisplatin, pemetrexed", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 3, "radiation_details": [{"type": "External", "start": "117", "end": "152", "duration": 35, "dosis": "60", "dosis_unit": "Gy"}, {"type": "External", "start": "117", "end": "152", "duration": 35, "dosis": "50.4", "dosis_unit": "Gy"}, {"type": "External", "start": "117", "end": "152", "duration": 35, "dosis": "45", "dosis_unit": "Gy"}]}, {"uuid": "37007f0a-f8bd-4f3e-bdb7-5ac8eabff0a3", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage IV", "histological_type": "Epithelioid mesothelioma", "days_to_death": "328", "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Ancillary", "name": "Porfimer Sodium (Photofin)", "start": "25", "end": "28", "duration": 3, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3890d394-8538-4470-b267-195198e0bdfa", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage II", "histological_type": "Epithelioid mesothelioma", "days_to_death": "197", "age_at_initial_pathologic_diagnosis": "46", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": null, "name": null, "start": "42", "end": "56", "duration": 14, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "103", "end": "168", "duration": 65, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Alimta", "start": "103", "end": "168", "duration": 65, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "162", "end": "162", "duration": 0, "dosis": "8", "dosis_unit": "Gy"}]}, {"uuid": "49490f36-9f29-46eb-b48c-76d806fc8cd7", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": "", "days_to_last_followup": "228", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "136", "end": "228", "duration": 92, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Alimta", "start": "136", "end": "228", "duration": 92, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "eb9268b7-d630-4510-9a2d-b718179d9058", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Sarcomatoid mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Ancillary", "name": "2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-alpha (HPPH or Photochlor)", "start": "199", "end": "202", "duration": 3, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "105a2544-eb7e-405c-9eac-dc9965314b81", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": "", "days_to_last_followup": "1575", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": null, "end": "117", "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Alimta", "start": null, "end": "117", "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": null, "end": "665", "duration": "", "dosis": null, "dosis_unit": null}]}, {"uuid": "0c96ebdc-4a5c-4a7b-b0e1-ecce35f87011", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage IV", "histological_type": "Epithelioid mesothelioma", "days_to_death": "459", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Pemetrexed", "start": "58", "end": "163", "duration": 105, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "58", "end": "163", "duration": 105, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed", "start": "388", "end": "429", "duration": 41, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "388", "end": "429", "duration": 41, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": null, "start": "455", "end": "458", "duration": 3, "dosis": "16", "dosis_unit": "Gy"}]}, {"uuid": "03510041-3245-449f-99b2-23d55dce65c4", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Biphasic mesothelioma", "days_to_death": "76", "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2ff03bce-06f8-4ef6-9cd9-2e8ab4ed5606", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Diffuse malignant mesothelioma - NOS", "days_to_death": "719", "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "308", "end": "462", "duration": 154, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Alimta", "start": "693", "end": "693", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Sutent", "start": "608", "end": "651", "duration": 43, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "308", "end": "462", "duration": 154, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0638c025-d9c1-42c5-a463-eab9d741882c", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage IV", "histological_type": "Biphasic mesothelioma", "days_to_death": "84", "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b2e93bec-a1ba-4ab2-b358-28c54f36bda9", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": "885", "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 9, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Dasatinib", "start": "38", "end": "66", "duration": 28, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "120", "end": "386", "duration": 266, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed", "start": "120", "end": "386", "duration": 266, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "imatinib", "start": "120", "end": "386", "duration": 266, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "everolimus", "start": "120", "end": "386", "duration": 266, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "736", "end": "800", "duration": 64, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Doxorubicin", "start": "471", "end": "604", "duration": 133, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "471", "end": "604", "duration": 133, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Temsirolimus", "start": "471", "end": "604", "duration": 133, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ff07d76b-6954-41af-bc5c-23ffe1282ed5", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage IB", "histological_type": "Biphasic mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": "", "days_to_last_followup": "7", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b91031b0-2d29-4df0-82f2-9194dea2ef7d", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage IV", "histological_type": "Epithelioid mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "36", "days_to_last_known_alive": "", "days_to_last_followup": "261", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Pemetrexed", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": null, "end": "261", "duration": "", "dosis": null, "dosis_unit": null}]}, {"uuid": "b10f3616-7c68-451c-a743-fefa742a0c29", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage I", "histological_type": "Epithelioid mesothelioma", "days_to_death": "563", "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Ancillary", "name": "Porfimer Sodium (Photofrin)", "start": "51", "end": "54", "duration": 3, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1da3a0b5-8c55-4340-9177-91751029ce85", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": "", "days_to_last_followup": "577", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "24", "end": "66", "duration": 42, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed", "start": "24", "end": "66", "duration": 42, "dosis": null, "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": "External", "start": "189", "end": "232", "duration": 43, "dosis": "45", "dosis_unit": "Gy"}, {"type": "External", "start": "189", "end": "232", "duration": 43, "dosis": "54", "dosis_unit": "Gy"}]}, {"uuid": "efa10658-a9d0-43d3-876d-c4f3ce4f34c6", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Biphasic mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": "", "days_to_last_followup": "200", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "29", "end": "92", "duration": 63, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed", "start": "29", "end": "92", "duration": 63, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "132", "end": "168", "duration": 36, "dosis": "4680", "dosis_unit": "cGy"}]}, {"uuid": "55e583ee-8116-45aa-8d85-f2761aa9a48b", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage IV", "histological_type": "Epithelioid mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": "", "days_to_last_followup": "1426", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 6, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Amatuximab (MORab-009)", "start": "61", "end": "509", "duration": 448, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "61", "end": "173", "duration": 112, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed (Alimta)", "start": "61", "end": "173", "duration": 112, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "GDC-0980", "start": "802", "end": "1060", "duration": 258, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Tivantinib (ARQ-197)", "start": "1286", "end": "1430", "duration": 144, "dosis": null, "dosis_unit": null}, {"type": null, "name": "DS-8273a", "start": "1446", "end": "1489", "duration": 43, "dosis": null, "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": null, "start": "1524", "end": "1551", "duration": 27, "dosis": "50", "dosis_unit": "Gy"}, {"type": null, "start": "1543", "end": "1551", "duration": 8, "dosis": "15.4", "dosis_unit": "Gy"}]}, {"uuid": "e769b553-b67f-4164-b1da-0f8fb326904e", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Biphasic mesothelioma", "days_to_death": "243", "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "153", "end": "195", "duration": 42, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed", "start": "153", "end": "195", "duration": 42, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "06034a43-14a0-48db-a983-f86fa212bcc7", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": "789", "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "94", "end": "94", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "148", "end": "183", "duration": 35, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "94", "end": "183", "duration": 89, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8cf1a518-b578-4ef6-bb7e-3b8baf49ac68", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": "", "days_to_last_followup": "803", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Dasatinib", "start": "91", "end": "123", "duration": 32, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "435", "end": "461", "duration": 26, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed", "start": "435", "end": "461", "duration": 26, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "236", "end": "271", "duration": 35, "dosis": "45", "dosis_unit": "Gy"}]}, {"uuid": "56c4f925-e124-418b-9961-2551ffe759f3", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage II", "histological_type": "Epithelioid mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": "-8", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "076d0f01-7706-4be1-a274-5adf7d5e9b8b", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Biphasic mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": "", "days_to_last_followup": "463", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Targeted Molecular therapy", "name": null, "start": "379", "end": "463", "duration": 84, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "162", "end": "302", "duration": 140, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed (Alimta)", "start": "162", "end": "302", "duration": 140, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": null, "start": "118", "end": "120", "duration": 2, "dosis": "21", "dosis_unit": "Gy"}]}, {"uuid": "4b075740-5181-4b04-8908-3a5ebdf7bcb9", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage I", "histological_type": "Epithelioid mesothelioma", "days_to_death": "144", "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "891bd951-0428-41e0-acac-1cee7b529172", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage II", "histological_type": "Epithelioid mesothelioma", "days_to_death": "406", "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "62", "end": "92", "duration": 30, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "113", "end": "161", "duration": 48, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Alimta", "start": "62", "end": "161", "duration": 99, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "322", "end": "335", "duration": 13, "dosis": "30", "dosis_unit": "Gy"}]}, {"uuid": "35a736c8-aac2-4971-8193-56ad8c8fe346", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage IV", "histological_type": "Epithelioid mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": "285", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": null, "start": null, "end": "257", "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed", "start": "56", "end": "178", "duration": 122, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "56", "end": "178", "duration": 122, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed", "start": "481", "end": "602", "duration": 121, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f0dc583a-b816-4ee8-9c13-9b75a7b429e7", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage II", "histological_type": "Epithelioid mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": "", "days_to_last_followup": "739", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "679", "end": "707", "duration": 28, "dosis": "5000", "dosis_unit": "cGy"}]}, {"uuid": "a8bbdf2d-cb5c-4047-b56d-be94cd028358", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": "757", "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine (Gemzar)", "start": "22", "end": "519", "duration": 497, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "22", "end": "519", "duration": 497, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Alimta", "start": "519", "end": "672", "duration": 153, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "10c37f9a-62ca-4968-9c5c-1eb3db4eb8a8", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage II", "histological_type": "Epithelioid mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": "444", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Pemetrexed", "start": "24", "end": "66", "duration": 42, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "24", "end": "66", "duration": 42, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "160", "end": "218", "duration": 58, "dosis": "54", "dosis_unit": "Gy"}]}, {"uuid": "02fb79d0-7d98-4d66-8867-fde84ec771a4", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Biphasic mesothelioma", "days_to_death": "107", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": null, "name": "Tetrathiomolybdate", "start": "73", "end": "96", "duration": 23, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e16b1ea3-0b0e-4098-8de4-3c6f1365a158", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage II", "histological_type": "Epithelioid mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": "", "days_to_last_followup": "1316", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatinum", "start": "11", "end": "133", "duration": 122, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Alimta", "start": "11", "end": "133", "duration": 122, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}]}, {"uuid": "1bfbd07b-1ae5-4308-8f2e-c179b40a39bc", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": "", "days_to_last_followup": "524", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Pemetrexed", "start": "83", "end": "146", "duration": 63, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "83", "end": "146", "duration": 63, "dosis": null, "dosis_unit": null}, {"type": "Vaccine", "name": null, "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "182", "end": "219", "duration": 37, "dosis": "4680", "dosis_unit": "cGy"}]}, {"uuid": "b7d33b30-ad09-44d2-bcaf-7811b4ed489c", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": "358", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Ancillary", "name": "Porfimer Sodium (Photofin)", "start": "39", "end": "42", "duration": 3, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5ee140f7-9e84-4d8f-8eb6-02a81ec465f2", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage IA", "histological_type": "Epithelioid mesothelioma", "days_to_death": "795", "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Ancillary", "name": "2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-alpha (HPPH or Photochlor)", "start": "51", "end": "54", "duration": 3, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e038b10d-23ac-48c6-82ee-093fe948459d", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage IV", "histological_type": "Biphasic mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": "", "days_to_last_followup": "501", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "603cc76d-e07d-4b56-861a-569a42660fe8", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage IV", "histological_type": "Biphasic mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": "", "days_to_last_followup": "439", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "551", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": null, "start": "439", "end": "467", "duration": 28, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "74", "end": "215", "duration": 141, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed (Alimta)", "start": "74", "end": "215", "duration": 141, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1ef2053e-7ae9-4a05-9790-11c8e42075db", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": "826", "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Dasatinib", "start": "90", "end": "110", "duration": 20, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9f63713e-a151-4914-9cc5-499c7897fe5f", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage IV", "histological_type": "Epithelioid mesothelioma", "days_to_death": "881", "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 7, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "25", "end": "25", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed", "start": "25", "end": "25", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "EVERolimus", "start": "391", "end": "543", "duration": 152, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "564", "end": "711", "duration": 147, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "571", "end": "634", "duration": 63, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed", "start": "739", "end": "760", "duration": 21, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Vinorelbine", "start": "790", "end": "816", "duration": 26, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "110", "end": "148", "duration": 38, "dosis": "5040", "dosis_unit": "cGy"}]}, {"uuid": "df469d49-758b-4f46-ae11-e67fa66bdb6f", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": "", "days_to_last_followup": "371", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "CISPLATINUM", "start": "60", "end": "60", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "118", "end": "174", "duration": 56, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Alimta", "start": "118", "end": "174", "duration": 56, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Adriamycin", "start": "187", "end": "274", "duration": 87, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d4456a28-165f-4659-9d29-9e88fe9ca133", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": "689", "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Ancillary", "name": "Porfimer Sodium (Photofrin)", "start": "17", "end": "20", "duration": 3, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0e12c03c-738f-4d1e-9083-95149cf76a1b", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": "297", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Pemetrexed", "start": "74", "end": "137", "duration": 63, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "74", "end": "137", "duration": 63, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "169", "end": "209", "duration": 40, "dosis": "5040", "dosis_unit": "cGy"}]}, {"uuid": "bdc8e3b5-f471-42c3-801c-32bc9caf2f7d", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage I", "histological_type": "Biphasic mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": "", "days_to_last_followup": "499", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "46aaed02-5226-4bdf-b91d-e10cff6c9f01", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage I", "histological_type": "Epithelioid mesothelioma", "days_to_death": "253", "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "152", "end": "203", "duration": 51, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed", "start": "152", "end": "203", "duration": 51, "dosis": null, "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": "External", "start": "215", "end": "233", "duration": 18, "dosis": "18", "dosis_unit": "Gy"}, {"type": "External", "start": "15", "end": "16", "duration": 1, "dosis": "8", "dosis_unit": "Gy"}]}, {"uuid": "1d38f082-0ce9-47c0-b404-58aae504c818", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Biphasic mesothelioma", "days_to_death": "527", "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8addf259-efb6-47c7-a178-6d814bfa8d5f", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": "727", "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "165", "end": "278", "duration": 113, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed", "start": "165", "end": "278", "duration": 113, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "573", "end": "649", "duration": 76, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed", "start": "573", "end": "649", "duration": 76, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "280", "end": "280", "duration": 0, "dosis": "21", "dosis_unit": "Gy"}]}, {"uuid": "adb428b2-e822-4c83-8f80-93c910935955", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage II", "histological_type": "Epithelioid mesothelioma", "days_to_death": "244", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "36", "end": "36", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "bd32cb39-8458-47ee-86de-22d66fb46c6f", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Diffuse malignant mesothelioma - NOS", "days_to_death": "843", "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "cef47779-316f-406f-8ce6-c2ddaf72a069", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage II", "histological_type": "Epithelioid mesothelioma", "days_to_death": "572", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": null, "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "cisplatin", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemzar", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2fc01ec0-5cfc-4a37-82a6-3f1e1f7c4610", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": "", "days_to_last_followup": "485", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "137", "end": "228", "duration": 91, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pemetrexed (Alimta)", "start": "137", "end": "228", "duration": 91, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": null, "start": "627", "end": "627", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6e52ca7d-d60f-420b-adc5-667be73912b9", "tumor_tissue_site": "Pleura", "pathologic_stage": "Stage III", "histological_type": "Epithelioid mesothelioma", "days_to_death": "591", "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": "", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}]